Hence, blocking Gal-3, as shown in our NMR data (Supplementary Figure S2 & S3), indicates that PL-M binds specifically to Gal-3 in the μM range and could potentially create a broad-spectrum anti-influenza treatment [39]. This evidence concerns the gene LGALS3 and influenza.